Desloratadine interactions
Full monograph for DesloratadineCheck it against another medicine
Medicines
390 documented
| Medicine | Severity | Mechanism | Effect | Sources |
|---|---|---|---|---|
| ErythromycinLotionOral | Minor | Metabolism | Erythromycin and ketoconazole may increase the plasma concentrations of desloratadine and its metabolite. The probable mechanism is inhibition of CYP450… | 1 sources — open the full entry |
| Ketoconazole | Minor | Metabolism | Erythromycin and ketoconazole may increase the plasma concentrations of desloratadine and its metabolite. The probable mechanism is inhibition of CYP450… | 1 sources — open the full entry |
| Ketoconazole + Zinc Pyrithione + Aleovera | Minor | Metabolism | Erythromycin and ketoconazole may increase the plasma concentrations of desloratadine and its metabolite. The probable mechanism is inhibition of CYP450… | 1 sources — open the full entry |
Conditions
Conditions in which Desloratadine needs care, as documented in this source.
Asthma
ModerateDesloratadine products contain sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people. Caution is advised when using these products in people with asthma.
1 source
- "Product Information. Clarinex (desloratadine)." Schering Corporation (2002):
Liver Diseases
ModerateDosing adjustment of desloratadine is recommended for patients with renal or hepatic impairment. Dosing recommendations for children with liver or renal impairment cannot be made due to lack of data.
1 source
- "Product Information. Clarinex (desloratadine)." Schering Corporation (2002):